Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

A Pilot Study About the Dysfunction of Adipose Tissue in Male, Sleep Apneic Patients in Relation to Psychological Symptoms.

Trakada G, Nikolaidis PT, Economou NT, Sakkas D, Giagkou G, Sakellariou S, Kyriakopoulou K, Patsouris E, Ferini-Strambi L, Velentza L, Kallianos A, Rosemann T, Knechtle B, Mitrakou A.

Front Psychiatry. 2019 Jul 25;10:527. doi: 10.3389/fpsyt.2019.00527. eCollection 2019.

2.

Clinical Characteristics of Obstructive Sleep Apnea in Psychiatric Disease.

Knechtle B, Economou NT, Nikolaidis PT, Velentza L, Kallianos A, Steiropoulos P, Koutsompolis D, Rosemann T, Trakada G.

J Clin Med. 2019 Apr 18;8(4). pii: E534. doi: 10.3390/jcm8040534.

3.

Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcome.

Trakada G, Kastritis E, Gavriatopoulou M, Velentza L, Fotiou D, Ziogas DC, Panagiotidis I, Eleutherakis-Papaiakovou E, Roussou M, Migkou M, Kanellias N, Ntanasis-Stathopoulos I, Kallianos A, Terpos E, Dimopoulos MA.

Ann Hematol. 2019 Jun;98(6):1427-1434. doi: 10.1007/s00277-019-03641-x. Epub 2019 Mar 5.

PMID:
30834954
4.

Comorbidities in coexisting chronic obstructive pulmonary disease and obstructive sleep apnea - overlap syndrome.

Papachatzakis I, Velentza L, Zarogoulidis P, Kallianos A, Trakada G.

Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4325-4331. doi: 10.26355/eurrev_201807_15429.

5.

Sleepiness, fatigue, anxiety and depression in Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea - Overlap - Syndrome, before and after continuous positive airways pressure therapy.

Economou NT, Ilias I, Velentza L, Papachatzakis Y, Zarogoulidis P, Kallianos A, Trakada G.

PLoS One. 2018 Jun 11;13(6):e0197342. doi: 10.1371/journal.pone.0197342. eCollection 2018.

6.

Convex-probe endobronchial ultrasound for thyroid biopsy a new hybrid method.

Sapalidis K, Kosmidis C, Laskou S, Zarogoulidis P, Karapantzos I, Karapantzou C, Kallianos A, Hohenforst-Schmidt W, Karanikas M, Thomaidis V, Huang H, Bai C, Kesisoglou I.

Respir Med Case Rep. 2018 Feb 2;23:125-127. doi: 10.1016/j.rmcr.2018.01.012. eCollection 2018.

7.

Hamman's syndrome (spontaneous pneumomediastinum presenting as subcutaneous emphysema): A rare case of the emergency department and review of the literature.

Grapatsas K, Tsilogianni Z, Leivaditis V, Kotoulas S, Kotoulas C, Koletsis E, Iliadis IS, Dahm M, Trakada G, Veletza L, Kallianos A, Huang H, Kosmidis C, Karanikas M, Thomaidis V, Porpodis K, Zarogoulidis P.

Respir Med Case Rep. 2017 Dec 11;23:63-65. doi: 10.1016/j.rmcr.2017.12.004. eCollection 2018.

8.

A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking.

Zarogoulidis P, Huang H, Bai C, Kosmidis C, Porpodis K, Kallianos A, Veletza L, Trakada G, Benhassen N, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Nov 28;23:38-42. doi: 10.1016/j.rmcr.2017.11.006. eCollection 2018.

9.

Successful treatment of postoperative massive pulmonary embolism with paradoxal arterial embolism through extracorporeal life support and thrombolysis.

Grapatsas K, Leivaditis V, Zarogoulidis P, Tsilogianni Z, Kotoulas S, Kotoulas C, Koletsis E, Iliadis IS, Spiliotopoulos K, Trakada G, Veletza L, Kallianos A, Tsiouda T, Kosmidis C, Hohenforst-Schmidt W, Huang H, Haussmann R, Haussmann E, Dahm M.

Respir Med Case Rep. 2017 Oct 31;23:1-3. doi: 10.1016/j.rmcr.2017.10.014. eCollection 2018.

10.

Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.

Zarogoulidis P, Huang H, Tsiouda T, Sardeli C, Trakada G, Veletza L, Kallianos A, Kosmidis C, Rapti A, Papaemmanouil L, Hatzibougias D, Drougas D, Bai C, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Oct 26;22:283-286. doi: 10.1016/j.rmcr.2017.10.006. eCollection 2017.

11.

Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.

Zarogoulidis P, Athanasiou E, Tsiouda T, Hatzibougias D, Huang H, Bai C, Trakada G, Veletza L, Kallianos A, Kosmidis C, Barbetakis N, Paliouras D, Rapti A, Drougas D, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Aug 29;22:197-202. doi: 10.1016/j.rmcr.2017.08.017. eCollection 2017.

12.

Endobronchial ultrasound convex probe for lymphoma, sarcoidosis, lung cancer and other thoracic entities. A case series.

Zarogoulidis P, Huang H, Bai C, Kosmidis C, Trakada G, Veletza L, Tsiouda T, Barbetakis N, Paliouras D, Athanasiou E, Hatzibougias D, Kallianos A, Panagiotopoulos N, Papaemmanouil L, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Aug 19;22:187-196. doi: 10.1016/j.rmcr.2017.08.016. eCollection 2017.

13.

EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50.

Zarogoulidis P, Chinelis P, Efthymiou C, Athanasiadou A, Mpikos V, Papatsibas G, Papadopoulos V, Maragouli E, Huang H, Trakada G, Kallianos A, Veletza L, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 May 30;22:7-10. doi: 10.1016/j.rmcr.2017.05.010. eCollection 2017.

14.

Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases.

Zarogoulidis P, Chinelis P, Athanasiadou A, Tsiouda T, Trakada G, Kallianos A, Veletza L, Hatzibougias D, Mihalopoulou E, Goupou E, Kosmidis C, Sardeli C, Huang H, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Jul 14;22:101-105. doi: 10.1016/j.rmcr.2017.07.004. eCollection 2017.

15.

"Liquid elbows" due to afatinib administration.

Zarogoulidis P, Chinelis P, Athanasiadou A, Porpodis K, Kallianos A, Rapti A, Trakada G, Velentza L, Huang H, Tsiouda T, Hohenforst-Schmidt W.

Respir Med Case Rep. 2017 Jun 23;22:64-66. doi: 10.1016/j.rmcr.2017.06.013. eCollection 2017.

16.

Re-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case series.

Zarogoulidis P, Rapti A, Sardeli C, Chinelis P, Athanasiadou A, Paraskevaidou K, Kallianos A, Veletza L, Trakada G, Hohenforst-Schmidt W, Huang H.

Respir Med Case Rep. 2017 May 30;21:171-175. doi: 10.1016/j.rmcr.2017.05.013. eCollection 2017.

17.

Progressive dyspnea due to pulmonary carcinoid tumorlets.

Kallianos A, Velentza L, Zarogoulidis P, Baka S, Kosmidis C, Labaki S, Lazaridis G, Huang H, Hohenforst-Schmidt W, Trakada G.

Respir Med Case Rep. 2017 Apr 6;21:84-85. doi: 10.1016/j.rmcr.2017.03.024. eCollection 2017.

18.

Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome.

Kallianos A, Panoutsopoulos A, Mermigkis C, Kostopoulos K, Papamichail C, Kokkonouzis I, Kostopoulos C, Nikolopoulos I, Papaiwannou A, Lampaki S, Organtzis J, Pitsiou G, Zarogoulidis P, Trakada G.

Clin Interv Aging. 2015 Aug 19;10:1361-6. doi: 10.2147/CIA.S84199. eCollection 2015.

19.

Reduction of exercise capacity in sarcoidosis in relation to disease severity.

Kallianos A, Zarogoulidis P, Ampatzoglou F, Trakada G, Gialafos E, Pitsiou G, Pataka A, Veletza L, Zarogoulidis K, Hohenforst-Schmidt W, Petridis D, Kioumis I, Rapti A.

Patient Prefer Adherence. 2015 Aug 18;9:1179-88. doi: 10.2147/PPA.S86465. eCollection 2015.

20.

CPAP therapy induces favorable short-term changes in epicardial fat thickness and vascular and metabolic markers in apparently healthy subjects with obstructive sleep apnea-hypopnea syndrome (OSAHS).

Kostopoulos K, Alhanatis E, Pampoukas K, Georgiopoulos G, Zourla A, Panoutsopoulos A, Kallianos A, Velentza L, Zarogoulidis P, Trakada G.

Sleep Breath. 2016 May;20(2):483-93. doi: 10.1007/s11325-015-1236-5. Epub 2015 Jul 30.

PMID:
26223484
21.

Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection.

Kallianos A, Rapti A, Tsimpoukis S, Charpidou A, Dannos I, Kainis E, Syrigos K.

In Vivo. 2014 Nov-Dec;28(6):1013-20. Review.

PMID:
25398794
22.

Enhancement of Aerosol Cisplatin Chemotherapy with Gene Therapy Expressing ABC10 protein in Respiratory System.

Hohenforst-Schmidt W, Zarogoulidis P, Linsmeier B, Kioumis I, Li Q, Huang H, Sachpatzidou D, Lampaki S, Organtzis J, Domvri K, Sakkas L, Zachariadis GA, Archontas KN, Kallianos A, Rapti A, Yarmus L, Zarogoulidis K, Brachmann J.

J Cancer. 2014 Mar 24;5(5):344-50. doi: 10.7150/jca.9021. eCollection 2014.

23.

Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach.

Petridis D, Zarogoulidis P, Kallianos A, Kioumis I, Trakada G, Spyratos D, Papaiwannou A, Porpodis K, Huang H, Rapti A, Hohenforst-Schmidt W, Zarogoulidis K.

Ther Clin Risk Manag. 2014 Feb 7;10:77-86. doi: 10.2147/TCRM.S57429. eCollection 2014.

24.

Occupational exposure and lung cancer.

Spyratos D, Zarogoulidis P, Porpodis K, Tsakiridis K, Machairiotis N, Katsikogiannis N, Kougioumtzi I, Dryllis G, Kallianos A, Rapti A, Li C, Zarogoulidis K.

J Thorac Dis. 2013 Sep;5 Suppl 4:S440-5. doi: 10.3978/j.issn.2072-1439.2013.07.09. Review.

25.

Therapeutic procedure in small cell lung cancer.

Kallianos A, Rapti A, Zarogoulidis P, Tsakiridis K, Mpakas A, Katsikogiannis N, Kougioumtzi I, Li Q, Huang H, Zaric B, Perin B, Courcoutsakis N, Zarogoulidis K.

J Thorac Dis. 2013 Sep;5 Suppl 4:S420-4. doi: 10.3978/j.issn.2072-1439.2013.09.16. Review.

26.

Glucose and arterial blood pressure variability in Obstructive Sleep Apnea Syndrome.

Kallianos A, Trakada G, Papaioannou T, Nikolopouloss I, Mitrakou A, Manios E, Kostopoulos K, Kostopoulos C, Zakopoulos N.

Eur Rev Med Pharmacol Sci. 2013 Jul;17(14):1932-7.

27.

Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today.

Kallianos A, Tsimpoukis S, Zarogoulidis P, Darwiche K, Charpidou A, Tsioulis I, Trakada G, Porpodis K, Spyratos D, Panoutsopoulos A, Veletza L, Kostopoulos K, Kostopoulos C, Karapantzos I, Tsakiridis K, Hohenforst-Schmidt W, Zarogoulidis K, Rapti A, Syrigos K.

Onco Targets Ther. 2013 May 31;6:609-13. doi: 10.2147/OTT.S44087. Print 2013.

28.

Lymphangioleiomyomatosis: current and future.

Mavroudi M, Zarogoulidis P, Katsikogiannis N, Tsakiridis K, Huang H, Sakkas A, Kallianos A, Rapti A, Sarika E, Karapantzos I, Zarogoulidis K.

J Thorac Dis. 2013 Feb;5(1):74-9. doi: 10.3978/j.issn.2072-1439.2013.01.03.

29.

Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors.

Rapti A, Kouranos V, Gialafos E, Aggeli K, Moyssakis J, Kallianos A, Kostopoulos C, Anagnostopoulou O, Sfikakis PP, Wells AU, Tzelepis GE.

Lung. 2013 Feb;191(1):61-7. doi: 10.1007/s00408-012-9442-4. Epub 2012 Dec 11.

PMID:
23229755
30.

Effect of CPAP treatment on endothelial function and plasma CRP levels in patients with sleep apnea.

Panoutsopoulos A, Kallianos A, Kostopoulos K, Seretis C, Koufogiorga E, Protogerou A, Trakada G, Kostopoulos C, Zakopoulos N, Nikolopoulos I.

Med Sci Monit. 2012 Dec;18(12):CR747-51.

31.

Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010.

Zarogoulidis P, Glaros D, Kioumis I, Terzi E, Porpodis K, Tsiotsios A, Kallianos A, Trakada G, Machairiotis N, Stylianaki A, Sakas A, Rapti A, Courcoutsakis N, Constantinidis TC, Maltezos E, Zarogoulidis K.

Int J Gen Med. 2012;5:675-82. doi: 10.2147/IJGM.S34940. Epub 2012 Aug 13.

32.

Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections.

Zarogoulidis P, Glaros D, Kontakiotis T, Froudarakis M, Kioumis I, Kouroumichakis I, Tsiotsios A, Kallianos A, Steiropoulos P, Porpodis K, Nena E, Papakosta D, Rapti A, Constantinidis TC, Kerenidi T, Panopoulou M, Trakada G, Courcoutsakis N, Fouka E, Zarogoulidis K, Maltezos E.

Int J Gen Med. 2012;5:175-82. doi: 10.2147/IJGM.S28454. Epub 2012 Mar 5.

33.

Association of sarcoidosis with endothelial function, arterial wall properties, and biomarkers of inflammation.

Siasos G, Tousoulis D, Gialafos E, Oikonomou E, Zaromitidou M, Aggeli C, Korompelis P, Kallianos A, Rapti A, Zisimos K, Marinos G, Stefanadis C, Papavassiliou AG.

Am J Hypertens. 2011 Jun;24(6):647-53. doi: 10.1038/ajh.2011.30. Epub 2011 Mar 3.

PMID:
21372802
34.

Detection of right ventricular dysfunction by tissue Doppler imaging in asymptomatic patients with pulmonary sarcoidosis.

Gialafos E, Rapti A, Kouranos V, Aggeli K, Papaioannou TG, Kallianos A, Siasos G, Kostopoulos C, Stefanadis C.

Eur Respir J. 2011 Jan;37(1):212-5. doi: 10.1183/09031936.00065210. No abstract available.

35.

How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?

Mermigkis C, Stagaki E, Tryfon S, Schiza S, Amfilochiou A, Polychronopoulos V, Panagou P, Galanis N, Kallianos A, Mermigkis D, Kopanakis A, Varouchakis G, Kapsimalis F, Bouros D.

Sleep Breath. 2010 Dec;14(4):387-90. doi: 10.1007/s11325-010-0336-5. Epub 2010 Mar 16.

PMID:
20232261
36.

Identification of the D-glucosides of stigmasterol, sitosterol and campesterol in tobacco and cigarette smoke.

KALLIANOS AG, SHELBURNE FA, MEANS RE, STEVENS RK, LAX RE, MOLD JD.

Biochem J. 1963 Jun;87:596-600. No abstract available.

37.

Metabolic studies of quercetin labeled with C14.

PETRAKIS PL, KALLIANOS AG, WENDER SH, SHETLAR MR.

Arch Biochem Biophys. 1959 Nov;85:264-71. No abstract available.

PMID:
14432284
38.

Preliminary studies on degradation products of quercetin in the rat's gastrointestinal tract.

KALLIANOS AG, PETRAKIS PL, SHETLAR MR, WENDER SH.

Arch Biochem Biophys. 1959 Apr;81(2):430-3. No abstract available.

PMID:
13638006

Supplemental Content

Loading ...
Support Center